CD274 and gastric cancer: EBVaGC accounts for about 9% of all gastric cancers (GCs) and displays a unique molecular signature compared with other GC subtypes, including showing unique DNA hypermethylation as well as upregulation of programmed death ligands 1 and 2 (PD-L1/2).5